De-identification of medical images is a critical step to ensure privacy during data sharing in research and clinical settings. The initial step in this process involves detecting Protected Health Information (PHI), which can be found in image metadata or imprinted within image pixels. Despite the importance of such systems, there has been limited evaluation of existing AI-based solutions, creating barriers to the development of reliable and robust tools. In this study, we present an AI-based pipeline for PHI detection, comprising three key modules: text detection, text extraction, and text analysis. We benchmark three models-YOLOv11, EasyOCR, and GPT-4o- across different setups corresponding to these modules, evaluating their performance on two different datasets encompassing multiple imaging modalities and PHI categories. Our findings indicate that the optimal setup involves utilizing dedicated vision and language models for each module, which achieves a commendable balance in performance, latency, and cost associated with the usage of large language models (LLMs). Additionally, we show that the application of LLMs not only involves identifying PHI content but also enhances OCR tasks and facilitates an end-to-end PHI detection pipeline, showcasing promising outcomes through our analysis.

Multimodal image registration is crucial in medical imaging, particularly for aligning Magnetic Resonance Imaging (MRI) and Transrectal Ultrasound (TRUS) data, which are widely used in prostate cancer diagnosis and treatment planning. However, this task presents significant challenges due to the inherent differences between these imaging modalities, including variations in resolution, contrast, and noise. Recently, conventional Convolutional Neural Network (CNN)-based registration methods, while effective at extracting local features, often struggle to capture global contextual information and fail to adapt to complex deformations in multimodal data. Conversely, Transformer-based methods excel at capturing long-range dependencies and hierarchical features but face difficulties in integrating fine-grained local details, which are essential for accurate spatial alignment. To address these limitations, we propose a novel 3D image registration framework that combines the strengths of both paradigms. Our method employs a Swin Transformer (ST)-CNN encoder-decoder architecture, with a key innovation focusing on enhancing the skip connection stages. Specifically, we introduce an innovative module named Wavelet-3D-Depthwise-Attention (WDA). The WDA module leverages an attention mechanism that integrates wavelet transforms for multi-scale spatial-frequency representation and 3D-Depthwise convolution to improve computational efficiency and modality fusion. Experimental evaluations on clinical MRI/TRUS datasets confirm that the proposed method achieves a median Dice score of 0.94 and a target registration error of 0.85, indicating an improvement in registration accuracy and robustness over existing state-of-the-art (SOTA) methods. The WDA-enhanced skip connections significantly empower the registration network to preserve critical anatomical details, making our method a promising advancement in prostate multimodal registration. Furthermore, the proposed framework shows strong potential for generalization to other image registration tasks.

Efficient processing of radiology reports for monitoring disease progression is crucial in oncology. Although large language models (LLMs) show promise in extracting structured information from medical reports, privacy concerns limit their clinical implementation. This study evaluates the feasibility and accuracy of two of the most recent Llama models for generating structured lymphoma progression reports from cross-sectional imaging data in a privacy-preserving, real-world clinical setting. This single-center, retrospective study included adult lymphoma patients who underwent cross-sectional imaging and treatment between July 2023 and July 2024. We established a chain-of-thought prompting strategy to leverage the locally deployed Llama-3.3-70B-Instruct and Llama-4-Scout-17B-16E-Instruct models to generate lymphoma disease progression reports across three iterations. Two radiologists independently scored nodal and extranodal involvement, as well as Lugano staging and treatment response classifications. For each LLM and task, we calculated the F1 score, accuracy, recall, precision, and specificity per label, as well as the case-weighted average with 95% confidence intervals (CIs). Both LLMs correctly implemented the template structure for all 65 patients included in this study. Llama-4-Scout-17B-16E-Instruct demonstrated significantly greater accuracy in extracting nodal and extranodal involvement information (nodal: 0.99 [95% CI = 0.98-0.99] vs. 0.97 [95% CI = 0.95-0.96], p < 0.001; extranodal: 0.99 [95% CI = 0.99-1.00] vs. 0.99 [95% CI = 0.98-0.99], p = 0.013). This difference was more pronounced when predicting Lugano stage and treatment response (stage: 0.85 [95% CI = 0.79-0.89] vs. 0.60 [95% CI = 0.53-0.67], p < 0.001; treatment response: 0.88 [95% CI = 0.83-0.92] vs. 0.65 [95% CI = 0.58-0.71], p < 0.001). Neither model produced hallucinations of newly involved nodal or extranodal sites. The highest relative error rates were found when interpreting the level of disease after treatment. In conclusion, privacy-preserving LLMs can effectively extract clinical information from lymphoma imaging reports. While they excel at data extraction, they are limited in their ability to generate new clinical inferences from the extracted information. Our findings suggest their potential utility in streamlining documentation and highlight areas requiring optimization before clinical implementation.

The integration of pathology and radiology in medical imaging has emerged as a critical need for advancing diagnostic accuracy and improving clinical workflows. Current AI-driven approaches for medical image analysis, despite significant progress, face several challenges, including handling multi-modal imaging, imbalanced datasets, and the lack of robust interpretability and uncertainty quantification. These limitations often hinder the deployment of AI systems in real-world clinical settings, where reliability and adaptability are essential. To address these issues, this study introduces a novel framework, the Domain-Informed Adaptive Network (DIANet), combined with an Adaptive Clinical Workflow Integration (ACWI) strategy. DIANet leverages multi-scale feature extraction, domain-specific priors, and Bayesian uncertainty modeling to enhance interpretability and robustness. The proposed model is tailored for multi-modal medical imaging tasks, integrating adaptive learning mechanisms to mitigate domain shifts and imbalanced datasets. Complementing the model, the ACWI strategy ensures seamless deployment through explainable AI (XAI) techniques, uncertainty-aware decision support, and modular workflow integration compatible with clinical systems like PACS. Experimental results demonstrate significant improvements in diagnostic accuracy, segmentation precision, and reconstruction fidelity across diverse imaging modalities, validating the potential of this framework to bridge the gap between AI innovation and clinical utility.

Thyroid incidentalomas (TIs) are incidental thyroid lesions detected on fluorodeoxy-d-glucose (18F-FDG) PET/computed tomography (PET/CT) scans. This study aims to investigate the role of noninvasive PET/CT-derived radiomic features in characterizing 18F-FDG PET/CT TIs and distinguishing benign from malignant thyroid lesions in oncological patients. We included 46 patients with PET/CT TIs who underwent thyroid ultrasound and thyroid surgery at our oncological referral hospital. Radiomic features extracted from regions of interest (ROI) in both PET and CT images and analyzed for their association with thyroid cancer and their predictive ability. The TIs were graded using the ultrasound TIRADS classification, and histopathological results served as the reference standard. Univariate and multivariate analyses were performed using features from each modality individually and combined. The performance of radiomic features was compared to the TIRADS classification. Among the 46 included patients, 36 patients (78%) had malignant thyroid lesions, while 10 patients (22%) had benign lesions. The combined run length nonuniformity radiomic feature from PET and CT cubical ROIs demonstrated the highest area under the curve (AUC) of 0.88 (P < 0.05), with a negative correlation with malignancy. This performance was comparable to the TIRADS classification (AUC: 0.84, P < 0.05), which showed a positive correlation with thyroid cancer. Multivariate analysis showed higher predictive performance using CT-derived radiomics (AUC: 0.86 ± 0.13) compared to TIRADS (AUC: 0.80 ± 0.08). This study highlights the potential of 18F-FDG PET/CT-derived radiomics to distinguish benign from malignant thyroid lesions. Further studies with larger cohorts and deep learning-based methods could obtain more robust results.

Medical image segmentation is a complex and challenging task, which aims to accurately segment various structures or abnormal regions in medical images. However, obtaining accurate segmentation results is difficult because of the great uncertainty in the shape, location, and scale of the target region. To address these challenges, we propose a higher-order spatial interaction framework with dual cross global efficient attention (DGEAHorNet), which employs a neural network architecture based on recursive gate convolution to adequately extract multi-scale contextual information from images. Specifically, a Dual Cross-Attentions (DCA) is added to the skip connection that can effectively blend multi-stage encoder features and narrow the semantic gap. In the bottleneck stage, global channel spatial attention module (GCSAM) is used to extract image global information. To obtain better feature representation, we feed the output from the GCSAM into the multi-branch dense layer (SENetV2) for excitation. Furthermore, we adopt Depthwise Over-parameterized Convolutional Layer (DO-Conv) in order to replace the common convolutional layer in the input and output part of our network, then add Efficient Attention (EA) to diminish computational complexity and enhance our model's performance. For evaluating the effectiveness of our proposed DGEAHorNet, we conduct comprehensive experiments on four publicly-available datasets, and achieving 0.9320, 0.9337, 0.9312 and 0.7799 in Dice similarity coefficient on ISIC2018, ISIC2017, CVC-ClinicDB and HRF respectively. Our results show that DGEAHorNet has better performance compared with advanced methods. The code is publicly available at https://github.com/penghaixin/mymodel .

Artificial intelligence (AI) is rapidly transforming health care, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication. This study aimed to examine patient perspectives on AI use in health care, particularly in diagnostic processes and communication, identifying key concerns, expectations, and opportunities to guide the development and implementation of AI tools. This study used a qualitative focus group methodology with co-design principles to explore patient and family member perspectives on AI in clinical practice. A single 2-hour session was conducted with 17 adult participants. The session included interactive activities and breakout sessions focused on five specific AI scenarios relevant to diagnosis and communication: (1) portal messaging, (2) radiology review, (3) digital scribe, (4) virtual human, and (5) decision support. The session was audio-recorded and transcribed, with facilitator notes and demographic questionnaires collected. Data were analyzed using inductive thematic analysis by 2 independent researchers (GF and JB), with discrepancies resolved via consensus. Participants reported varying comfort levels with AI applications contingent on the level of patient interaction, with digital scribe (average 4.24, range 2-5) and radiology review (average 4.00, range 2-5) being the highest, and virtual human (average 1.68, range 1-4) being the lowest. In total, five cross-cutting themes emerged: (1) validation (concerns about model reliability), (2) usability (impact on diagnostic processes), (3) transparency (expectations for disclosing AI usage), (4) opportunities (potential for AI to improve care), and (5) privacy (concerns about data security). Participants valued the co-design session and felt they had a significant say in the discussions. This study highlights the importance of incorporating patient perspectives in the design and implementation of AI tools in health care. Transparency, human oversight, clear communication, and data privacy are crucial for patient trust and acceptance of AI in diagnostic processes. These findings inform strategies for individual clinicians, health care organizations, and policy makers to ensure responsible and patient-centered AI deployment in health care.

To assess changes in peer-reviewed evidence on commercially available radiological artificial intelligence (AI) products from 2020 to 2023, as a follow-up to a 2020 review of 100 products. A literature review was conducted, covering January 2015 to March 2023, focusing on CE-certified radiological AI products listed on www.healthairegister.com . Papers were categorised using the hierarchical model of efficacy: technical/diagnostic accuracy (levels 1-2), clinical decision-making and patient outcomes (levels 3-5), or socio-economic impact (level 6). Study features such as design, vendor independence, and multicentre/multinational data usage were also examined. By 2023, 173 CE-certified AI products from 90 vendors were identified, compared to 100 products in 2020. Products with peer-reviewed evidence increased from 36% to 66%, supported by 639 papers (up from 237). Diagnostic accuracy studies (level 2) remained predominant, though their share decreased from 65% to 57%. Studies addressing higher-efficacy levels (3-6) remained constant at 22% and 24%, with the number of products supported by such evidence increasing from 18% to 31%. Multicentre studies rose from 30% to 41% (p < 0.01). However, vendor-independent studies decreased (49% to 45%), as did multinational studies (15% to 11%) and prospective designs (19% to 16%), all with p > 0.05. The increase in peer-reviewed evidence and higher levels of evidence per product indicate maturation in the radiological AI market. However, the continued focus on lower-efficacy studies and reductions in vendor independence, multinational data, and prospective designs highlight persistent challenges in establishing unbiased, real-world evidence. Question Evaluating advancements in peer-reviewed evidence for CE-certified radiological AI products is crucial to understand their clinical adoption and impact. Findings CE-certified AI products with peer-reviewed evidence increased from 36% in 2020 to 66% in 2023, but the proportion of higher-level evidence papers (~24%) remained unchanged. Clinical relevance The study highlights increased validation of radiological AI products but underscores a continued lack of evidence on their clinical and socio-economic impact, which may limit these tools' safe and effective implementation into clinical workflows.

The rapid advancement of artificial intelligence (AI) in healthcare has accelerated innovations in medical algorithms, yet its broader adoption faces critical ethical and technical barriers. A key challenge lies in algorithmic bias stemming from heterogeneous medical data across institutions, equipment, and workflows, which may perpetuate disparities in AI-driven diagnoses and exacerbate inequities in patient care. While AI's ability to extract deep features from large-scale data offers transformative potential, its effectiveness heavily depends on standardized, high-quality datasets. Current standardization gaps not only limit model generalizability but also raise concerns about reliability and fairness in real-world clinical settings, particularly for marginalized populations. Addressing these urgent issues, this paper proposes an ethical AI framework centered on a novel self-supervised medical image standardization method. By integrating self-supervised image style conversion, channel attention mechanisms, and contrastive learning-based loss functions, our approach enhances structural and style consistency in diverse datasets while preserving patient privacy through decentralized learning paradigms. Experiments across multi-institutional medical image datasets demonstrate that our method significantly improves AI generalizability without requiring centralized data sharing. By bridging the data standardization gap, this work advances technical foundations for trustworthy AI in healthcare.

This article, on the 60th anniversary of the journal Investigative Radiology, a journal dedicated to cutting-edge imaging technology, discusses key historical milestones in CT and MRI technology, as well as the ongoing advancement of contrast agent development for cardiovascular imaging over the past decades. It specifically highlights recent developments and the current state-of-the-art technology, including photon-counting detector CT and artificial intelligence, which will further push the boundaries of cardiovascular imaging. What were once ideas and visions have become today's clinical reality for the benefit of patients, and imaging technology will continue to evolve and transform modern medicine.